WOAG
WITHDRAWAL OF ATTORNEY GRANTED
02/10/2025
Back to search
Official data from USPTO
RESTRUX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
02/10/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/10/2020
Registration date
01/04/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2022
Last transaction
02/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/20/2021
First use in commerce
09/20/2021
Drawing code
4
Owner type
16
Owner location
St. Louis, MO
Examiner
KING, LINDA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Corelink, LLC
Representatives
Corelink, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissuecleaned and processed to remove cellular elementsintended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spineorthopedictrauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Publications
History of USPTO decisions and trademark events.
24 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
02/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/02/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/01/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/17/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/05/2021
IUAF
USE AMENDMENT FILED
10/19/2021
EISU
TEAS STATEMENT OF USE RECEIVED
10/19/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/25/2021
PUBO
PUBLISHED FOR OPPOSITION
05/25/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2021
GNRT
NON-FINAL ACTION E-MAILED
04/21/2021
CNRT
NON-FINAL ACTION WRITTEN
04/21/2021
DOCK
ASSIGNED TO EXAMINER
04/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2021
NWAP
NEW APPLICATION ENTERED
11/13/2020
Continuous trademark protection
Get notified about every new filing that threatens RESTRUX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.